Cargando…

Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone

BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Changliang, Shenoy, Anitha K., Padia, Ravi, Fang, Dongdong, Jing, Qing, Yang, Ping, Su, Shi-Bing, Huang, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171243/
https://www.ncbi.nlm.nih.gov/pubmed/30285892
http://dx.doi.org/10.1186/s13046-018-0902-4
_version_ 1783360758447341568
author Chen, Changliang
Shenoy, Anitha K.
Padia, Ravi
Fang, Dongdong
Jing, Qing
Yang, Ping
Su, Shi-Bing
Huang, Shuang
author_facet Chen, Changliang
Shenoy, Anitha K.
Padia, Ravi
Fang, Dongdong
Jing, Qing
Yang, Ping
Su, Shi-Bing
Huang, Shuang
author_sort Chen, Changliang
collection PubMed
description BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this study, we systematically analyzed known licorice’s constituents on the goal of identifying component(s) that can effectively suppress both cell migration and growth. METHODS: Effect of licorice’s constituents on cell growth was evaluated by MTT assay while cell migration was assessed by both wound-healing and Transwell assays. Cytoskeleton reorganization and focal adhesion assembly were visualized by immunofluorescence staining with labeled phalloidin and anti-paxillin antibody. Activity of Src in cells was judged by western blot using phosphor-Src416 antibody while Src kinase activity was measured using Promega Src kinase assay system. Anti-tumorigenic capabilities of isoliquiritigenin (ISL) and 2, 4, 2′, 4’-Tetrahydroxychalcone (THC) were investigated using lung cancer xenograft model. RESULTS: Using a panel of lung cancer cell lines, ISL was identified as the only licorice’s constituent capable of inhibiting both cell migration and growth. ISL-led inhibition in cell migration resulted from impaired cytoskeleton reorganization and focal adhesion assembly. Assessing the phosphorylation of 141 cytoskeleton dynamics-associated proteins revealed that ISL reduced the abundance of Tyr421-phosphorylation of cortactin, Tyr925- and Tyr861-phosphorylation of FAK, indicating the involvement of Src because these sites are known to be phosphorylated by Src. Enigmatically, ISL inhibited Src in cells while displayed no effect on Src activity in cell-free system. The discrepancy was explained by the observation that THC, one of the major ISL metabolite identified in lung cancer cells abrogated Src activity both in cells and cell-free system. Similar to ISL, THC deterred cell migration and abolished cytoskeleton reorganization/focal adhesion assembly. Furthermore, we showed both ISL and THC suppressed in vitro lung cancer cell invasion and in vivo tumor progression. CONCLUSION: Our study suggests that ISL inhibits lung cancer cell migration and tumorigenesis by interfering with Src through its metabolite THC. As licorice is safely used for culinary purposes, our study suggests that ISL or THC may be safely used as a Src inhibitor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0902-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6171243
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61712432018-10-10 Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone Chen, Changliang Shenoy, Anitha K. Padia, Ravi Fang, Dongdong Jing, Qing Yang, Ping Su, Shi-Bing Huang, Shuang J Exp Clin Cancer Res Research BACKGROUND: Licorice is an herb extensively used for both culinary and medicinal purposes. Various constituents of licorice have been shown to exhibit anti-tumorigenic effect in diverse cancer types. However, majority of these studies focus on the aspect of their growth-suppressive role. In this study, we systematically analyzed known licorice’s constituents on the goal of identifying component(s) that can effectively suppress both cell migration and growth. METHODS: Effect of licorice’s constituents on cell growth was evaluated by MTT assay while cell migration was assessed by both wound-healing and Transwell assays. Cytoskeleton reorganization and focal adhesion assembly were visualized by immunofluorescence staining with labeled phalloidin and anti-paxillin antibody. Activity of Src in cells was judged by western blot using phosphor-Src416 antibody while Src kinase activity was measured using Promega Src kinase assay system. Anti-tumorigenic capabilities of isoliquiritigenin (ISL) and 2, 4, 2′, 4’-Tetrahydroxychalcone (THC) were investigated using lung cancer xenograft model. RESULTS: Using a panel of lung cancer cell lines, ISL was identified as the only licorice’s constituent capable of inhibiting both cell migration and growth. ISL-led inhibition in cell migration resulted from impaired cytoskeleton reorganization and focal adhesion assembly. Assessing the phosphorylation of 141 cytoskeleton dynamics-associated proteins revealed that ISL reduced the abundance of Tyr421-phosphorylation of cortactin, Tyr925- and Tyr861-phosphorylation of FAK, indicating the involvement of Src because these sites are known to be phosphorylated by Src. Enigmatically, ISL inhibited Src in cells while displayed no effect on Src activity in cell-free system. The discrepancy was explained by the observation that THC, one of the major ISL metabolite identified in lung cancer cells abrogated Src activity both in cells and cell-free system. Similar to ISL, THC deterred cell migration and abolished cytoskeleton reorganization/focal adhesion assembly. Furthermore, we showed both ISL and THC suppressed in vitro lung cancer cell invasion and in vivo tumor progression. CONCLUSION: Our study suggests that ISL inhibits lung cancer cell migration and tumorigenesis by interfering with Src through its metabolite THC. As licorice is safely used for culinary purposes, our study suggests that ISL or THC may be safely used as a Src inhibitor. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-018-0902-4) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-03 /pmc/articles/PMC6171243/ /pubmed/30285892 http://dx.doi.org/10.1186/s13046-018-0902-4 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chen, Changliang
Shenoy, Anitha K.
Padia, Ravi
Fang, Dongdong
Jing, Qing
Yang, Ping
Su, Shi-Bing
Huang, Shuang
Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title_full Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title_fullStr Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title_full_unstemmed Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title_short Suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-Tetrahydroxychalcone
title_sort suppression of lung cancer progression by isoliquiritigenin through its metabolite 2, 4, 2’, 4’-tetrahydroxychalcone
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171243/
https://www.ncbi.nlm.nih.gov/pubmed/30285892
http://dx.doi.org/10.1186/s13046-018-0902-4
work_keys_str_mv AT chenchangliang suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT shenoyanithak suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT padiaravi suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT fangdongdong suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT jingqing suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT yangping suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT sushibing suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone
AT huangshuang suppressionoflungcancerprogressionbyisoliquiritigeninthroughitsmetabolite2424tetrahydroxychalcone